PTC THERAPEUTICS, INC. — Form D

PTC THERAPEUTICS, INC. of SOUTH PLAINFIELD, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2013-05-15. The offering totals $4.5M, of which $4.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
Richard B AldrichDirectorSouth Plainfield, NJ
Axel P BolteDirectorSouth Plainfield, NJ
Adam P KoppelDirectorSouth Plainfield, NJ
Michael P KrandaDirectorSouth Plainfield, NJ
Geoffrey P McDonoughDirectorSouth Plainfield, NJ
Claudia W HirawatExecutive OfficerSouth Plainfield, NJ
Stepanie S OkeyDirectorSouth Plainfield, NJ
Michael B SchmertzlerDirectorSouth Plainfield, NJ
Matthew B Klein, M.D.DirectorSouth Plainfield, NJ
Matthew B Klein, M.D.Executive OfficerSouth Plainfield, NJ
Eric E PauwelsExecutive OfficerSouth Plainfield, NJ
Alethia P YoungDirectorSouth Plainfield, NJ
Neil B Almstead, Ph.DExecutive OfficerSouth Plainfield, NJ
Glenn D Steele Jr., M.D., Ph.D.DirectorSouth Plainfield, NJ
David P SouthwellDirectorSouth Plainfield, NJ
Emily E HillExecutive OfficerSouth Plainfield, NJ
Jerome B Zeldis, M.D., Ph.D.DirectorSouth Plainfield, NJ
Mark E BouldingExecutive OfficerSouth Plainfield, NJ
Christine E UtterExecutive OfficerSouth Plainfield, NJ
Allan D Jacobson, Ph.D.DirectorSouth Plainfield, NJ
Emma B ReeveDirectorSouth Plainfield, NJ
Mary D SmithDirectorSouth Plainfield, NJ
Stuart W PeltzDirectorSouth Plainfield, NJ
Stuart W PeltzExecutive OfficerSouth Plainfield, NJ
Matthew S KleinExecutive OfficerSouth Plainfield, NJ

Other filings by this issuer (9)

FiledFormOfferingSold
2023-05-08D$35.9M$35.9M
2020-06-12D$41.9M$41.9M
2020-05-14D$140.9M$140.9M
2018-09-05D$150.0M$150.0M
2013-03-21D$60.0M$60.0M
2013-02-12D$16.1M$2.0M
2012-06-13D$40.0M$23.0M
2009-12-22D$50.3M$25.2M
2009-10-07D$1.0M

More